In a study that examined whether PPIs were associated with the development of CDAD in hospitalized patients, the authors found that PPIs did not raise the incidence of this disease, which is caused by a prevalent bacterial infection.
You are here
P&T® Journal contents for August 2007
Gastric Acid Suppression by Proton Pump Inhibitors as an Independent Risk Factor for Clostridium difficile–Associated Diarrhea
Sessions from three meetings included discussions of arformoterol and indacaterol for chronic obstructive pulmonary disease, pegylated interferon with or without ribavirin and its role in hepatitis C virus infection, ambrisentan for pulmonary arterial hypertension, and olmesartan/amlodipine combinations for hypertension.
The author presents a detailed account of the causes, diagnosis, prognosis, and therapies for colorectal cancer, including some promising biologic agents under development.
Author: Robert I. Field, JD, MPH, PhD